Production (Stage)
Krystal Biotech, Inc.
KRYS
$136.94
$4.323.26%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.60% | 12.28% | 4.67% | 17.19% | 53.62% |
| Total Receivables | 122.22% | 149.16% | 944.42% | -- | -- |
| Inventory | 171.29% | 279.50% | 252.05% | -- | -- |
| Prepaid Expenses | 158.29% | 97.94% | 63.97% | 19.39% | 28.62% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 27.32% | 26.22% | 22.51% | 41.07% | 69.44% |
|
|
|||||
| Total Current Assets | 27.32% | 26.22% | 22.51% | 41.07% | 69.44% |
| Net Property, Plant & Equipment | -4.75% | -4.03% | -4.86% | -3.42% | -2.36% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.22% | -12.17% | -28.77% | -55.79% | -51.24% |
| Total Assets | 25.91% | 29.02% | 24.29% | 34.16% | 60.44% |
|
|
|||||
| Total Accounts Payable | -50.14% | 20.64% | 28.57% | 22.02% | 30.42% |
| Total Accrued Expenses | 224.75% | 190.82% | 269.70% | 225.85% | 124.44% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -4.76% | -17.44% | -13.92% | -10.99% | -7.92% |
| Total Finance Division Other Current Liabilities | -28.30% | 360.53% | 292.41% | 307.19% | 5.94% |
| Total Other Current Liabilities | -28.30% | 360.53% | 292.41% | 307.19% | 5.94% |
| Total Current Liabilities | 67.03% | 208.20% | 224.57% | 200.66% | 35.67% |
|
|
|||||
| Total Current Liabilities | 67.03% | 208.20% | 224.57% | 200.66% | 35.67% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 28.38% | -8.70% | -9.31% | -9.81% | -10.27% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 66.02% | 175.62% | 180.43% | 154.80% | 27.84% |
|
|
|||||
| Common Stock & APIC | 5.69% | 7.58% | 7.31% | 7.92% | 30.97% |
| Retained Earnings | 46.10% | 33.04% | 18.80% | 29.49% | 17.53% |
| Treasury Stock & Other | 230.43% | -129.78% | 495.81% | -168.64% | -94.16% |
| Total Common Equity | 23.20% | 21.54% | 17.18% | 28.45% | 63.26% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 23.20% | 21.54% | 17.18% | 28.45% | 63.26% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 23.20% | 21.54% | 17.18% | 28.45% | 63.26% |
|
|
|||||